STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics

Pathology

Volumn 46, Issue 5, 2014, Pages 389-395

  Cheah, Alison L ^a   Billings, Steven D ^a   Goldblum, John R ^a   Carver, Paula ^a   Tanas, Munir Z ^a   Rubin, Brian P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Haemangiopericytoma; Solitary fibrous tumour; STAT6

Indexed keywords

MONOCLONAL ANTIBODY; STAT6 PROTEIN; STAT6 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ANIMAL; BIOSYNTHESIS; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RABBIT; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; SOLITARY FIBROUS TUMORS; TISSUE MICROARRAY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RABBITS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; SOLITARY FIBROUS TUMORS; STAT6 TRANSCRIPTION FACTOR; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906811406     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000122     Document Type: Article

References (39)

1. Fletcher CD, Bridge JA, Hogendoorn P, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon: IARC, 2013.
2. Goldblum JR, Folpe AL, Weiss SW, editors. Enzinger and Weiss's Soft Tissue Tumors. 6th ed. Philadelphia: Elsevier, 2013.
3. Brunnemann RB, Ro JY, Ordonez NG, et al. Extrapleural solitary fibrous tumor:Aclinicopathologic study of 24 cases.ModPathol 1999; 12: 1034-42.
4. Cerda-Nicolas M, Lopez-Gines C, Gil-Benso R, et al. Solitary fibrous tumor of the orbit: Morphological, cytogenetic and molecular features. Neuropathology 2006; 26: 557-63.
5. Croxatto JO, Font RL. Hemangiopericytoma of the orbit: A clinicopathologic study of 30 cases. Hum Pathol 1982; 13: 210-8.
6. Folpe AL, Devaney K,Weiss SW. Lipomatous hemangiopericytoma: A rare variant of hemangiopericytoma that may be confused with liposarcoma. Am J Surg Pathol 1999; 23: 1201-7.
7. Guillou L, Gebhard S, Coindre JM. Lipomatous hemangiopericytoma: A fat-containing variant of solitary fibrous tumor? clinicopathologic, immunohistochemical, and ultrastructural analysis of a series in favor of a unifying concept. Hum Pathol 2000; 31: 1108-15.
8. Hasegawa T, Matsuno Y, Shimoda T, et al. Extrathoracic solitary fibrous tumors: Their histological variability and potentially aggressive behavior. Hum Pathol 1999; 30: 1464-73.
9. Dei Tos AP, Seregard S, Calonje E, et al. Giant cell angiofibroma. A distinctive orbital tumor in adults. Am J Surg Pathol 1995; 19: 1286-93.
10. Hanau CA, Miettinen M. Solitary fibrous tumor: Histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995; 26: 440-9.
11. Nielsen GP, O'Connell JX, Dickersin GR, Rosenberg AE. Solitary fibrous tumor of soft tissue: A report of 15 cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod Pathol 1997; 10: 1028-37.
12. van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 1994; 18: 814-20.
13. Chmielecki J, Crago AM, Rosenberg M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 2013; 45: 131-2.
14. Robinson DR, Wu YM, Kalyana-Sundaram S, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 2013; 45: 180-5.
15. Mohajeri A, Tayebwa J, Collin A, et al. Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer 2013; 52: 873-86.
16. Schweizer L, Koelsche C, Sahm F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 2013; 125: 651-8.
17. Wurster A, Tanaka T, Grusby MJ. The biology of Stat4 and Stat6. Oncogene 2000; 19: 2577-84.
18. Doyle LA, Vivero M, Fletcher CD, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 2014; 27: 390-5.
19. Doyle LA, Tao DL, Marino-Enriquez A. STAT6 is amplified in a subset of dedifferentiated liposarcoma. Mod Pathol 2014; Jan 24: (Epub ahead of print).
20. Mandahl N, Orndal C, Heim S, et al. Aberrations of chromosome segment 12q13-15 characterize a subgroup of hemangiopericytomas. Cancer 1993; 71: 3009-13.
21. Martin AJ, Summersgill BM, Fisher C, Shipley JM, Dean AF. Chromosomal imbalances in meningeal solitary fibrous tumors. Cancer Genet Cytogenet 2002; 135: 160-4.
22. Debiec-Rychter M, deWever I, Hagemeijer A, Sciot R. Is 4q13 a recurring breakpoint in solitary fibrous tumors? Cancer Genet Cytogenet 2001; 131: 69-73.
23. Hoshino M, Ogose A, Kawashima H, et al. Malignant solitary fibrous tumor of the soft tissue: A cytogenetic study. Cancer Genet Cytogenet 2007; 177: 55-8.
24. Torabi A, Lele SM, DiMaio D, et al. Lack of a common or characteristic cytogenetic anomaly in solitary fibrous tumor. Cancer Genet Cytogenet 2008; 181: 60-4.
25. Srinivasan R, Mager GM,Ward RM, et al. NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex. J Biol Chem 2006; 281: 15129-37.
26. Svaren J, Sevetson BR, Apel ED, et al. NAB2, a corepressor of NGFI-A (egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol 1996; 16: 3545-53.
27. Srinivasan R, Jang SW, Ward RM, et al. Differential regulation of NAB corepressor genes in schwann cells. BMC Mol Biol 2007; 8: 117.
28. Abdulkadir SA, Carbone JM, Naughton CK, et al. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol 2001; 32: 935-9.
29. Beckmann AM, Wilce PA. Egr transcription factors in the nervous system. Neurochem Int 1997; 31: 477-510.
30. Liu C, Calogero A, Ragona G, et al. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity. Crit Rev Oncog 1996; 7: 101-25.
31. Thiel G, Cibelli G. Regulation of life and death by the zinc finger transcription factor egr-1. J Cell Physiol 2002; 193: 287-92.
32. Eid MA, Kumar MV, Iczkowski KA, et al. Expression of early growth response genes in human prostate cancer. Cancer Res 1998; 58: 2461-8.
33. Abdulkadir SA, Qu Z, Garabedian E, et al. Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med 2001; 7: 101-7.
34. Bruns HA, Kaplan MH. The role of constitutively active Stat6 in leukemia and lymphoma. Crit Rev Oncol Hematol 2006; 57: 245-53.
35. Das S, Roth CP, Wasson LM, Vishwanatha JK. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Prostate 2007; 67: 1550-64.
36. Guiter C, Dusanter-Fourt I, Copie-Bergman C, et al. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 2004; 104: 543-9.
37. Huang J, Ma G, Zhu M, et al. Molecular characterization of the porcine STAT4 and STAT6 genes. Mol Biol Rep 2012; 39: 6959-65.
38. Qin JZ, Kamarashev J, Zhang CL, et al. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol 2001; 117: 583-9.
39. Skinnider BF, Elia AJ, Gascoyne RD, et al. Signal transducer and activator of transcription 6 is frequently activated in hodgkin and reed-sternberg cells of hodgkin lymphoma. Blood 2002; 99: 618-26.